TipRanks
BridgeBio Pharma Inc (DE:2CL)
XETRA:2CL
Germany Market
2CL
BridgeBio Pharma
RESEARCH TOOLSreports

BridgeBio Pharma (2CL) Cash flow

3 Followers

BridgeBio Pharma Cash Flow

DE:2CL's free cash flow for Q2 2026 was $-223.78M. For the 2026 fiscal year, DE:2CL's free cash flow was decreased by $74.65M and operating cash flow was $-223.33M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -445.91M$ -520.73M$ -527.72M$ -419.49M$ -497.93M
Investing Cash Flow
$ -24.49M$ 60.78M$ 54.03M$ 453.15M$ -200.83M
Financing Cash Flow
$ 359.29M$ 748.46M$ 451.54M$ -13.13M$ 736.45M
End Cash Position
$ 572.14M$ 683.24M$ 394.73M$ 416.88M$ 396.37M
Free Cash Flow
$ -447.01M$ -521.66M$ -529.03M$ -425.81M$ -546.18M
Currency in USD

BridgeBio Pharma Cash Flow